Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS)
CNY 9.07
(3.66%)
CNY 9.07
(3.66%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 365.17 Million CNY | 13.92% |
| 2022 | 320.56 Million CNY | 31.68% |
| 2021 | 243.44 Million CNY | 28.01% |
| 2020 | 190.16 Million CNY | 1.18% |
| 2019 | 187.94 Million CNY | 45.48% |
| 2018 | 129.18 Million CNY | 2.26% |
| 2017 | 126.33 Million CNY | 110.32% |
| 2016 | 60.06 Million CNY | 32.96% |
| 2015 | 45.17 Million CNY | -5.42% |
| 2014 | 47.76 Million CNY | 51.1% |
| 2013 | 31.61 Million CNY | 312.49% |
| 2012 | 7.66 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 361.86 Million CNY | 16.28% |
| 2024 Q3 | 363.36 Million CNY | 0.41% |
| 2024 Q1 | 311.21 Million CNY | -14.78% |
| 2023 Q2 | 326.14 Million CNY | -2.99% |
| 2023 Q1 | 336.18 Million CNY | 4.87% |
| 2023 Q3 | 337.97 Million CNY | 3.63% |
| 2023 FY | 365.17 Million CNY | 13.92% |
| 2023 Q4 | 365.17 Million CNY | 8.05% |
| 2022 Q4 | 320.56 Million CNY | 5.33% |
| 2022 Q3 | 304.34 Million CNY | 2.31% |
| 2022 FY | 320.56 Million CNY | 31.68% |
| 2022 Q1 | 241.79 Million CNY | -0.68% |
| 2022 Q2 | 297.48 Million CNY | 23.03% |
| 2021 FY | 243.44 Million CNY | 28.01% |
| 2021 Q3 | 212.81 Million CNY | 5.07% |
| 2021 Q1 | 176.23 Million CNY | -7.33% |
| 2021 Q2 | 202.54 Million CNY | 14.92% |
| 2021 Q4 | 243.44 Million CNY | 14.39% |
| 2020 Q1 | 179.88 Million CNY | -4.29% |
| 2020 FY | 190.16 Million CNY | 1.18% |
| 2020 Q2 | 180.86 Million CNY | 0.55% |
| 2020 Q3 | 189.85 Million CNY | 4.97% |
| 2020 Q4 | 190.16 Million CNY | 0.16% |
| 2019 Q3 | 185.01 Million CNY | 14.31% |
| 2019 FY | 187.94 Million CNY | 45.48% |
| 2019 Q1 | 140.44 Million CNY | 8.72% |
| 2019 Q4 | 187.94 Million CNY | 1.58% |
| 2019 Q2 | 161.85 Million CNY | 15.24% |
| 2018 Q2 | 122.48 Million CNY | -1.05% |
| 2018 FY | 129.18 Million CNY | 2.26% |
| 2018 Q1 | 123.77 Million CNY | -2.02% |
| 2018 Q4 | 129.18 Million CNY | -3.08% |
| 2018 Q3 | 133.28 Million CNY | 8.82% |
| 2017 Q4 | 126.33 Million CNY | 4.39% |
| 2017 FY | 126.33 Million CNY | 110.32% |
| 2017 Q1 | 70.86 Million CNY | 17.97% |
| 2017 Q2 | 89.1 Million CNY | 25.74% |
| 2017 Q3 | 121.01 Million CNY | 35.81% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 FY | 60.06 Million CNY | 32.96% |
| 2016 Q4 | 60.06 Million CNY | 0.0% |
| 2015 Q1 | 47.73 Million CNY | 0.0% |
| 2015 FY | 45.17 Million CNY | -5.42% |
| 2014 FY | 47.76 Million CNY | 51.1% |
| 2013 FY | 31.61 Million CNY | 312.49% |
| 2012 FY | 7.66 Million CNY | 0.0% |